SCHEMBL25035376

SCHEMBL25035376

COc1cc2c(cc1Br)C(=O)/C(=C/c1ccc(OC)c(OC)c1)CO2

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 3/20 0.77
MAPT P10636 5/20 0.71
ALDH1A1 P00352 4/20 0.71
MAPK1 P28482 3/20 0.71
TP53 P04637 2/20 0.71
CYP3A4 P08684 2/20 0.71
LMNA P02545 2/20 0.71
SMN1; SMN2 Q16637 1/20 0.71
HPGD P15428 2/20 0.71
ATM Q13315 1/20 0.71
MAOB P27338 11/20 0.65
KDM4E B2RXH2 2/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
TDP1 Q9NUW8 2/20 0.58
USP2 O75604 1/20 0.58
ALOX15 P16050 1/20 0.58
HSD17B10 Q99714 1/20 0.58
CXCL12 P48061 1/20 0.57
PLIN1 O60240 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sappanone A Trimethyl Ether SCHEMBL25035400 0.83 MAPT (1.00) APPMAPTALDH1A1MAPK1TP53
Sappanone A Trimethyl Ether SCHEMBL14479888 0.83 MAPT (1.00) APPMAPTALDH1A1MAPK1TP53
Sappanone A Trimethyl Ether SCHEMBL30274257 0.83 MAPT (1.00) APPMAPTALDH1A1MAPK1TP53
SCHEMBL5725497 0.82 MAPT (0.77) APPMAPTALDH1A1MAPK1TP53
SCHEMBL8465773 0.82 APP (0.79) APPMAPTALDH1A1MAPK1TP53
SCHEMBL8465775 0.82 APP (0.79) APPMAPTALDH1A1MAPK1TP53
SCHEMBL5724831 0.75 MAOB (0.67) APPMAPTALDH1A1MAPK1TP53
SCHEMBL5725448 0.75 MAOB (0.67) APPMAPTALDH1A1MAPK1TP53
SCHEMBL25035409 0.74 CXCL12 (0.80) APPMAPTALDH1A1MAPK1TP53
SCHEMBL30274371 0.74 CXCL12 (0.80) APPMAPTALDH1A1MAPK1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129076-A1 FUSED TETRACYCLIC COMPOUNDS, COMPOSITIONS AND DIAGNOSTIC APPLICATIONS THEREOF BENAZIR FATHIMA (IN) 2025-04-24 US disclosed
WO-2023017548-A1 FUSED TETRACYCLIC COMPOUNDS, COMPOSITIONS AND DIAGNOSTIC APPLICATIONS THEREOF BENAZIR J DR FATHIMA (IN) 2023-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129076-A1 FUSED TETRACYCLIC COMPOUNDS, COMPOSITIONS AND DIAGNOSTIC APPLICATIONS THEREOF POLRMT, POLM, DNTT APP 1479/4885MAPT 144/4885ALDH1A1 1893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.